The effect of HIV programmes in South Africa on national HIV incidence trends, 2000-2019
Johnson LF, Meyer-Rath G, Dorrington RE, Puren A, Seathlodi T, Zuma K, et al. The effect of HIV programmes in South Africa on national HIV incidence trends, 2000-2019. J Acquir Immune Defic Syndr. 2022.
Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in south africa
Jennings L, Robbins RN, Nguyen N, Ferraris C, Leu CS, Dolezal C, et al. Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in south africa. Aids. 2022.
The Association of Reproductive Aging with Cognitive Function in Sub-Saharan African Women
Jaff NG, Crowther NJ. The Association of Reproductive Aging with Cognitive Function in Sub-Saharan African Women. Methods Mol Biol. 2022;2343:71-91.
It’s time to raise awareness of rare diseases in South Africa
Jacobson BF. Not so rare: It’s time to raise awareness of rare diseases in South Africa. S Afr Med J. 2022;112(1):13522.
Antibiotic Discovery and Resistance: The Chase and the Race. Antibiotics (Basel)
Iskandar K, Murugaiyan J, Hammoudi Halat D, Hage SE, Chibabhai V, Adukkadukkam S, et al. Antibiotic Discovery and Resistance: The Chase and the Race. Antibiotics (Basel). 2022;11(2).
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
Hussey H, Davies MA, Heekes A, Williamson C, Valley-Omar Z, Hardie D, et al. Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis. Int J Infect Dis. 2022;118:150-4.
